BBC3 and ovarian cancer: PUMA is expressed at a very low level under normal conditions, and upregulating PUMA expression using the adenoviral gene delivery technique in ovarian cancer cells is thought to exert better apoptosis-inducing effects but lower proliferation-inhibiting effects than those in cells transfected with the p53 gene [27].